机构：[1]PET/CT Center, Department of Nuclear Medicine, Sichuan Cancer Hospital and Institute, Sichuan Cancer Center, School of Medicine, University of Electronic Science and Technology of China四川省人民医院四川省肿瘤医院[2]Department of orthopedics, the People’s Hospital of Chengdu Tianfu New Area, Chengdu, Sichuan, People’s Republic of China.
第一作者机构：[1]PET/CT Center, Department of Nuclear Medicine, Sichuan Cancer Hospital and Institute, Sichuan Cancer Center, School of Medicine, University of Electronic Science and Technology of China
共同第一作者：
通讯作者：
通讯机构：[1]PET/CT Center, Department of Nuclear Medicine, Sichuan Cancer Hospital and Institute, Sichuan Cancer Center, School of Medicine, University of Electronic Science and Technology of China[*1]The PET/CT Center, Department of Nuclear Medicine, Sichuan Cancer Hospital and Institute, Sichuan Cancer Center, School of Medicine, University of Electronic Science and Technology of China, No.55, Section 4, South People’s Road, Chengdu, Sichuan 610041, People’s Republic of China.
推荐引用方式(GB/T 7714)：
Ying Kou,Zhiwei Yao,Zhuzhong Cheng.(AlF)-F-18-NOTA-FAPI-04 Outperforms F-18-FDG PET/CT in Identifying the Primary Lesion and Rare Metastases From Gastric Cancer[J].CLINICAL NUCLEAR MEDICINE.2021,46(12):E570-E571.doi:10.1097/RLU.0000000000003727.
APA：
Ying Kou,Zhiwei Yao&Zhuzhong Cheng.(2021).(AlF)-F-18-NOTA-FAPI-04 Outperforms F-18-FDG PET/CT in Identifying the Primary Lesion and Rare Metastases From Gastric Cancer.CLINICAL NUCLEAR MEDICINE,46,(12)
MLA：
Ying Kou,et al."(AlF)-F-18-NOTA-FAPI-04 Outperforms F-18-FDG PET/CT in Identifying the Primary Lesion and Rare Metastases From Gastric Cancer".CLINICAL NUCLEAR MEDICINE 46..12(2021):E570-E571
